Market Overview

9 Biotechnology Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

Immunogen, Inc. (NASDAQ:IMGN) shares rose 21.1% to $6.49 during Friday's pre-market session.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) stock rose 14.0% to $4.40. The most recent rating by PiperJaffray, on January 03, is at Overweight, with a price target of $8.00.

Genprex, Inc. (NASDAQ:GNPX) stock moved upwards by 11.3% to $3.05.

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) stock moved upwards by 11.1% to $26.50. The most recent rating by H.C. Wainwright, on January 08, is at Buy, with a price target of $30.00.

Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares surged 9.5% to $0.90. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $2.00.

Vaxart, Inc. (NASDAQ:VXRT) stock rose 6.5% to $1.14.

TG Therapeutics, Inc. (NASDAQ:TGTX) stock surged 4.7% to $15.90. The most recent rating by H.C. Wainwright, on January 17, is at Buy, with a price target of $24.00.

 

Losers

Sol-Gel Technologies, Inc. (NASDAQ:SLGL) shares decreased by 21.1% to $11.05 during Friday's pre-market session. The most recent rating by H.C. Wainwright, on December 31, is at Buy, with a price target of $26.00.

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) stock fell 3.3% to $56.53. The most recent rating by Nomura, on January 22, is at Buy, with a price target of $84.00.

Posted-In: Biotechnology Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

 

Related Articles (INO + IMGN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com